MRGPRG

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MRGPRG RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MRGPRG data layer compared with 2 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MRGPRG RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MRGPRG expression acts as an unfavorable survival marker, although some lineages such as OV and UCEC show a favorable association.

LUAD, LIHC, and COAD are the cancer types where MRGPRG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUADOSTertileAll0.1160.405.00263view →
LIHCOSTertileAll0.0510.783<.00154view →
COADDFSTertileIII,IV0.2300.732<.00145view →
UVMOSTertileAll0.2180.696.01436view →
OVOSMedianIV0.9150.615<.00136view →
KIRCDFSTertileAll0.5270.810.00224view →
HNSCOSTertileAll0.2880.608.03618view →
THYMDFSTertileII,III,IV0.1450.873<.00118view →
CESCDFSTertileIV0.2200.578.01018view →
KIRPOSTertileII,III,IV0.2160.771.0499view →
LUSCDFSTertileAll0.2350.528.0476view →
BLCADFSTertileAll0.4000.612.0446view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MRGPRG–LUAD (OS)

Kaplan–Meier survival curve for MRGPRG RNA-high vs -low samples in LUAD.

Open the LUAD breakdown →

Exploration